Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
135 participants
OBSERVATIONAL
2013-02-28
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)
NCT04437082
Tracking Optical Coherence Tomography
NCT00343603
Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100
NCT03505567
Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With SD-OCT
NCT02600546
Optical Coherence Tomography (OCT) Data Collection Study
NCT01459731
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retina
Having clinical diagnosis of retina pathology
No interventions assigned to this group
Glaucoma
Having clinical diagnosis of glaucoma
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years of age
* Able and willing to provide consent
* Willing to complete the required examinations and visits
* Best corrected visual acuity equal or better than 20/100
* Retina subject must have clinical diagnosis of retinal pathology
* Glaucoma subjects must have clinical diagnosis of glaucoma
Exclusion Criteria
* Poor OCT image quality as a result of media opacity, extreme refractive error or pathologies in the anterior segment
* Confounding pathology requiring surgical treatment or medical intervention
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Optovue
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pacific Eye Specialists
Daly City, California, United States
North Bay Eye Associates
Petaluma, California, United States
West Coast Retinal Medical Group
Walnut Creek, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20130104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.